2-Chlorodeoxyadenosine (cladribine) in combination with low-dose cyclosporin prevents rejection after allogeneic heart and liver transplantation in the rat

European Surgical Research

Volumn 30, Issue 1, 1998, Pages 61-68

  Schmid, T ^a   Hechenleitner, P ^a   Mark, W ^a   Fischer, M ^a   Roberts, K ^a   Geisen, F ^a   Klima, G ^a   Dietze, O ^b   Konwalinka, G ^a   Margreiter, R ^a,c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Salzburger Landeskliniken   (Austria)

^c Abt F Transplantationschirurgie   (Austria)

Author keywords

2 Chlorodeoxyadenosine; Cladribine; Heart transplantation; Immunosuppression; Liver transplantation; Rat

Indexed keywords

CLADRIBINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE GRAFT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; CLADRIBINE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RATS; RATS, INBRED BN; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS;

EID: 6844240867     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008559     Document Type: Article

References (25)

1. Calne R: Immunosuppression for organ grafting. Transplant Proc 1992;24:1260-1262.
2. Starzl TE, Hakala TR, Iwatsuki S, Rosenthal TJ, Shaw BW, Klintmalm GB, Porter KA: Cyclosporine A and steroid treatment in 104 cadaveric renal transplantations, in White DJG (ed): Cyclosporin A. Amsterdam, Elsevier Biomedical, 1982, p 365-373.
3. Slapak M, Geoghegan T, Gigard N, Ahmed K, Sharman VL, Crocket R: The use of low dose cyclosporin in combination with azathioprine and steroids in renal transplantation. Transplant Proc 1987;19:41-45.
4. Aichberger C, Eberl T, Riedmann B, Pernthaler H, Öfner D, Königsrainer A, Margreiter R: Long-term outcome after switch from cyclosporin-based triple-drug immunosuppression to double therapy at three months. Clin Transplant 1996;10: 209-212.
5. Kawamura T, Hullet DA, Suzuki Y, Bechstein WO, Allison AM, Sollinger HW: Enhancement of allograft survival by combination RS 61443 and DUP 785 therapy. Transplantation 1993;55:691-694.
6. Douglas Ensley R, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O'Connell JB, Dunn D, Osburn L, Jones KW, Kauffman RS, Gay WA, Renlund DG: The use of mycophenolate mofetil (RS 61443) in human heart transplantation recipients. Transplantation 1993;56:75-82.
7. Mizunok K, Tsujinom K, Takada M: Studies on brednin: I. Isolation, characterization and biological properties. J Antibiot 1974;17:220-225.
8. Cramer DV, Chapman FA, Jaffee BD, Jones EA, Knoop M, Hrcha-Eiras G, Makowka L: The effect of a new immunosuppression drug, brequinar sodium, on heart, liver and kidney allograft rejection in the rat. Transplantation 1992;53:303-308.
9. Tanabe M, Todo S, Murase N, Irih W, Miyazawa H, Fujisaki S, Starzl TE: Combined immunosuppressive therapy with low dose FK 506 and antimetabolites in rat allogeneic heart transplantation. Transplantation 1994;58:23-27.
10. Prior LD, Carrera CJ, Carson DA, Beutler E: Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121.
11. Beutler E: Cladribine (2-chlorodeoxyadenosine). Lancet 1992;340: 952-956.
12. Bryson H, Sorkin E: Cladnbine: A review of its pharmacodynamics, pharmacokinctics and therapeutic potential in the treatment of hematological malignancies. Drugs 1993; 46:872-894.
13. Oberhuber G, Schmid Th, Thaler W, Kaltenbacher A, Schirmern M, Liliemark J, Herbst P, Geisen F, Margreiter R, Konwalinka G: Evidence that 2-chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation. Transplantation 1994;58:743-745.
14. Carson DA, Wasson DB, Taetle R, Yu A: A specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 1983;62:737-743.
15. Cardinaud R: Nucleoside deoxyribosyltransferase from Lactobacillus helveticus Methods Enzymol 1978; 51:446-451.
16. Ono K, Lindsey ES: Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-229.
17. Zhao D, Wheatley AM: Orthotopic liver transplantation in the rat: Comparison of models with and without rearterialization of the graft. Eur Surg Res 1993;25:294-302.
18. Freireich EJ, Gehan EA, Rall DP, Schidt LH, Skipper HE: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966;550:219-223.
19. Williams JW, Peters TG, Vera SR, Britt LG, Van Voorst SJ, Haggit RC: Biopsy directed immunosuppression following hepatic transplantation in man. Transplantation 1985; 39:589-596.
20. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990;9:587-593.
21. Kahan BD, Yoshimura N, Pellis NR: Pharmacodynamics of cyclosporine. Transplant Proc 1986; 18: 238-251.
22. Kumar MSA, White AG, Alex G, Antos MS, Philips EM, Abouna GM: Correlation of blood levels and tissue levels of cyclosporine with the histologic features of cyclosporine toxicity. Transplant Proc 1988,20: 407-413.
23. Douglas Ensley R, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O'Connel JB, Dunn D, Osburn L, Jones KW, Kauffman RS, Gay WA, Renlund DG: The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation 1993;56:75-82.
24. Kriett JM, Kaye MP: The registry of the International Society for Heart Transplantation: Seventh official report - 1990. J Heart Transplant 1990;9:323-330.
25. Klintmalm GB, Nery JR, Husberg BS: Rejection in the liver transplantation. Hepatology 1989;10:978-985.